Cardiovascular disease and the kidney - Tracking a killer in chronic kidney disease

被引：31

作者：

Levin, A

Stevens, L

McCullough, PA

机构：

[1] Department of Medicine, University of British Columbia, Faculty of Medicine, Vancouver

[2] Division of Nephrology, University of British Columbia, Faculty of Medicine, Vancouver

[3] Clinic for Chronic Kidney Disease Care, St. Paul's Hospital, Vancouver

[4] Department of Medicine, University of Missouri-Kansas City, School of Medicine, Kansas City, MO

[5] Cardiology Section, Truman Medical Center, Kansas City, MO

[6] St Paul's Hospital, Vancouver, BC V6Z 1Y8

来源：

POSTGRADUATE MEDICINE | 2002年 / 111卷 / 04期

关键词：

D O I：

10.3810/pgm.2002.04.1168

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease (CVD) is prevalent in patients with chronic kidney disease (CKD) and is responsible for the majority of morbidity and mortality in this patient population. Although many identifiable risk factors and therapeutic strategies exist for treatment of CVD, most of them are underused in the care of patients who have kidney disease. In this article, Drs Levin, Stevens, and McCullough highlight the issues concerning treatment of CVD in patients who have CKD. Early recognition of both CKD and attendant CVD is becoming the purview of the primary care physician in conjunction with members of subspecialty teams.

引用

收藏

页码：53 / 60

页数：8

相关论文

共 31 条

[1] Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy [J].

Bakris, G ;

White, D .

JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (01) :35-38

[2] Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern? [J].

Bakris, GL ;

Weir, MR .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :685-693

[3] Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].

Bakris, GL ;

Williams, M ;

Dworkin, L ;

Elliott, WJ ;

Epstein, M ;

Toto, R ;

Tuttle, K ;

Douglas, J ;

Hsueh, W ;

Sowers, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661

[4] Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction [J].

Beattie, JN ;

Soman, SS ;

Sandberg, KR ;

Yee, J ;

Borzak, S ;

Garg, M ;

McCullough, PA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (06) :1191-1200

[5] Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management [J].

Block, GA ;

Port, FK .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1226-1237

[6] Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project [J].

Chertow, GM ;

Normand, SLT ;

Silva, LR ;

McNeil, BJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1044-1051

[7] Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency [J].

Culleton, BF ;

Larson, MG ;

Wilson, PWF ;

Evans, JC ;

Parfrey, PS ;

Levy, D .

KIDNEY INTERNATIONAL, 1999, 56 (06) :2214-2219

[8] The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease [J].

Foley, RN ;

Parfrey, PS ;

Harnett, JD ;

Kent, GM ;

Murray, DC ;

Barre, PE .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :53-61

[9] CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGE RENAL-DISEASE THERAPY [J].

FOLEY, RN ;

PARFREY, PS ;

HARNETT, JD ;

KENT, GM ;

MARTIN, CJ ;

MURRAY, DC ;

BARRE, PE .

KIDNEY INTERNATIONAL, 1995, 47 (01) :186-192

[10] Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials [J].

Giatras, I ;

Lau, J ;

Levey, AS .

ANNALS OF INTERNAL MEDICINE, 1997, 127 (05) :337-+

← 1 2 3 4 →